Answer
Toxic epidermal necrolysis (TEN) has been reported with Kisqali (ribociclib), which should be discontinued immediately if signs or symptoms suggestive of severe skin reactions appear.
Sources for this answer
- Kisqali film coated tabletsNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 25Document updated
Sources checked